Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Punjab, India.
Department of Pharmaceutical Sciences, School of Applied Sciences and Technology, University of Kashmir, Srinagar, J & K, India.
J Biomol Struct Dyn. 2022;40(24):14279-14302. doi: 10.1080/07391102.2021.1997818. Epub 2021 Nov 15.
Imidazopyridine scaffold has gained tremendous importance over the past few decades. Imidazopyridines have been expeditiously used for the rationale design and development of novel synthetic analogs for various therapeutic disorders. A wide variety of imidazopyridine derivatives have been developed as potential anti-cancer, anti-diabetic, anti-tubercular, anti-microbial, anti-viral, anti-inflammatory, central nervous system (CNS) agents besides other chemotherapeutic agents. Imidazopyridine heterocyclic system acts as a key pharmacophore motif for the identification and optimization of lead structures to increase medicinal chemistry toolbox. The present review highlights the medicinal significances of imidazopyridines for their rationale development as lead molecules with improved therapeutic efficacies. This review further emphasis on the structure-activity relationships (SARs) of the various designed imidazopyridines to establish a relationship between the key structural features versus the biological activities.Communicated by Ramaswamy H. Sarma.
咪唑并吡啶支架在过去几十年中变得非常重要。咪唑并吡啶已被迅速用于各种治疗障碍的新型合成类似物的合理设计和开发。已经开发出各种各样的咪唑并吡啶衍生物作为潜在的抗癌、抗糖尿病、抗结核、抗菌、抗病毒、抗炎、中枢神经系统 (CNS) 药物以及其他化疗药物。咪唑并吡啶杂环系统作为识别和优化先导结构以增加药物化学工具箱的关键药效团基序。本综述强调了咪唑并吡啶的药用意义,因为它们作为具有改善治疗效果的先导分子得到了合理的开发。本综述进一步强调了各种设计的咪唑并吡啶的构效关系 (SAR),以建立关键结构特征与生物活性之间的关系。由 Ramaswamy H. Sarma 传达。